Recent Advances in Nanoparticles for Mucosal Drug Delivery

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 319

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain
Interests: film technology; HIV/ADS prevention; mucoadhesion; topical pre-exposure prophylaxis; vaginal drug delivery
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain
Interests: drug controlled release; HIV; microbicides; mucoadhesiveness; natural polymers; vaginal route
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Drug delivery is possible through various administration routes, and most of them involve passage through mucous membranes (from absorption through the digestive tract after oral administration, to absorption through the buccal, sublingual, nasal, ocular, vaginal, rectal mucosa passageways, etc.). However, the characteristics of all the above-mentioned mucous membranes can differ greatly, in addition to their capacity for drug absorption. This implies the need for continuous research to optimize mucosal drug delivery systems.

In recent decades, nanomedicines have made it possible to significantly improve therapeutics, and mucosal delivery is no exception. Thus, nanotechnology has been harnessed to reach a specific therapeutic target, to increase the retention of formulations at the site of action or even to promote their permeability through mucosal tissue.

All articles that explore the use of nanoparticles for mucosal drug delivery, whatever their therapeutic target, are welcome in this Special Issue. This includes articles that propose the innovative development of nanoparticles, as well as those that deepen the results of its administration, and also bibliographic reviews that update the current state of the art in this field.

Dr. Fernando Notario-Pérez
Dr. Roberto Ruiz-Caro
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • bioavailability enhancement
  • controlled release
  • mucoadhesion
  • mucopenetration
  • nanocarriers
  • nanomedicines
  • targeted drug delivery
  • topical drug delivery
  • vaccine delivery

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop